These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 21696525
1. The use of everolimus in pediatric liver transplant recipients: first experience in a single center. Nielsen D, Briem-Richter A, Sornsakrin M, Fischer L, Nashan B, Ganschow R. Pediatr Transplant; 2011 Aug; 15(5):510-4. PubMed ID: 21696525 [Abstract] [Full Text] [Related]
2. Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma. Jiménez-Rivera C, Avitzur Y, Fecteau AH, Jones N, Grant D, Ng VL. Pediatr Transplant; 2004 Jun; 8(3):243-8. PubMed ID: 15176961 [Abstract] [Full Text] [Related]
3. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. De Simone P, Metselaar HJ, Fischer L, Dumortier J, Boudjema K, Hardwigsen J, Rostaing L, De Carlis L, Saliba F, Nevens F. Liver Transpl; 2009 Oct; 15(10):1262-9. PubMed ID: 19790150 [Abstract] [Full Text] [Related]
4. Everolimus in clinical practice in long-term liver transplantation: an observational study. Casanovas T, Argudo A, Peña-Cala MC. Transplant Proc; 2011 Oct; 43(6):2216-9. PubMed ID: 21839237 [Abstract] [Full Text] [Related]
5. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J. Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091 [Abstract] [Full Text] [Related]
6. A single center experience of combined liver kidney transplantation. Mehrabi A, Fonouni H, Ayoub E, Rahbari NN, Müller SA, Morath Ch, Seckinger J, Sadeghi M, Golriz M, Esmaeilzadeh M, Hillebrand N, Weitz J, Zeier M, Büchler MW, Schmidt J, Schmied BM. Clin Transplant; 2009 Dec 15; 23 Suppl 21():102-14. PubMed ID: 19930323 [Abstract] [Full Text] [Related]
7. Conversion to everolimus in liver transplant patients with renal dysfunction. Pérez T, Segovia R, Castro L, Roblero JP, Estela R. Transplant Proc; 2011 Dec 15; 43(6):2307-10. PubMed ID: 21839260 [Abstract] [Full Text] [Related]
8. Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients. Basso MS, Subramaniam P, Tredger M, Verma A, Heaton N, Rela M, Mieli-Vergani G, Dhawan A. Pediatr Transplant; 2011 Nov 15; 15(7):722-7. PubMed ID: 22004546 [Abstract] [Full Text] [Related]
9. Towards minimizing immunosuppression in pediatric liver transplant recipients. Turmelle YP, Nadler ML, Anderson CD, Doyle MB, Lowell JA, Shepherd RW. Pediatr Transplant; 2009 Aug 15; 13(5):553-9. PubMed ID: 19067920 [Abstract] [Full Text] [Related]
11. Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry. Ng VL, Fecteau A, Shepherd R, Magee J, Bucuvalas J, Alonso E, McDiarmid S, Cohen G, Anand R, Studies of Pediatric Liver Transplantation Research Group. Pediatrics; 2008 Dec 15; 122(6):e1128-35. PubMed ID: 19047213 [Abstract] [Full Text] [Related]
12. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency. Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q. Transplant Proc; 2008 Jun 15; 40(5):1541-4. PubMed ID: 18589147 [Abstract] [Full Text] [Related]
13. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction. Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E. Liver Transpl; 2009 Dec 15; 15(12):1792-7. PubMed ID: 19938140 [Abstract] [Full Text] [Related]
14. Conversion to everolimus monotherapy in maintenance liver transplantation: feasibility, safety, and impact on renal function. De Simone P, Carrai P, Precisi A, Petruccelli S, Baldoni L, Balzano E, Ducci J, Caneschi F, Coletti L, Campani D, Filipponi F. Transpl Int; 2009 Mar 15; 22(3):279-86. PubMed ID: 19054383 [Abstract] [Full Text] [Related]
15. Conversion to everolimus in kidney transplant recipients with decreased renal function. Inza A, Balda S, Alvarez E, Zárraga S, Gaínza FJ, Lampreabe I. Transplant Proc; 2009 Mar 15; 41(6):2134-6. PubMed ID: 19715854 [Abstract] [Full Text] [Related]
16. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation. Helal I, Chan L. Transplant Proc; 2011 Mar 15; 43(2):472-7. PubMed ID: 21440737 [Abstract] [Full Text] [Related]
17. Improvement in renal function and rejection control in pediatric liver transplant recipients with the introduction of sirolimus. Casas-Melley AT, Falkenstein KP, Flynn LM, Ziegler VL, Dunn SP. Pediatr Transplant; 2004 Aug 15; 8(4):362-6. PubMed ID: 15265163 [Abstract] [Full Text] [Related]
18. Replacing calcineurin inhibitors with mTOR inhibitors in children. Sindhi R, Seward J, Mazariegos G, Soltys K, Seward L, Smith A, Kosmach B, Venkataramanan R. Pediatr Transplant; 2005 Jun 15; 9(3):391-7. PubMed ID: 15910398 [Abstract] [Full Text] [Related]
19. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients. Tenderich G, Fuchs U, Zittermann A, Muckelbauer R, Berthold HK, Koerfer R. Clin Transplant; 2007 Jun 15; 21(4):536-43. PubMed ID: 17645716 [Abstract] [Full Text] [Related]